Lindbrook Capital’s Vericel Corp VCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding VCEL
BCM
CCA
CAM
GKIM
GCM
Lindbrook Capital's VCEL Position: Q1 2025 in Review
Lindbrook Capital increased its Vericel Corp (VCEL) stake by 117% in Q1 2025, buying an estimated $753 and bringing the position to 26 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2423.
Lindbrook Capital first reported a position in VCEL in Q3 2022 and has held it in 11 quarters since. The position peaked at $1.74K in Q2 2024. 277 funds tracked by Wall St. Rank hold VCEL as of Q1 2025.
- Lindbrook Capital held 26 shares of Vericel Corp worth $1.16K as of Q1 2025.
- Lindbrook Capital bought 14 Vericel Corp shares in Q1 2025, an estimated $753.
- Vericel Corp made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2423 holding.
- Lindbrook Capital first reported a position in Vericel Corp in Q3 2022 and has held it in 11 quarters since.
- Lindbrook Capital's Vericel Corp position peaked at $1.74K in Q2 2024.
- 277 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.